Biological properties of structurally related α-helical cationic antimicrobial peptides

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 2005-2009

  Scott, Monisha G ^a   Yan, Hong ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CARBENICILLIN; CIPROFLOXACIN; CYTOKINE; INTERLEUKIN 6; NALIDIXIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG POTENTIATION; ESCHERICHIA COLI; IMMUNE RESPONSE; MACROPHAGE FUNCTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STRUCTURE ACTIVITY RELATION;

EID: 0033003473     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.67.4.2005-2009.1999     Document Type: Article

References (26)

1. Amsterdam, D. 1991. Susceptibility testing of antimicrobials in liquid media, p. 72-78. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
2. Angus, B. L., A. M. Carey, D. A. Caron, A. M. B. Kropinski, and R. E. W. Hancock. 1982. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob. Agents Chemother. 21:299-309.
3. Bowman, H. G., D. Wade, I. A. Bowman, B. Wählin, and R. B. Merrifield. 1989. Antibacterial and antimalarial properties of peptides that are cecropinmelittin hybrids. FEBS Lett. 259:103-106.
4. Christ, W. J., O. Asano, A. L. C. Robidoux, M. Perez, Y. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. McGuinness, M. A. Mullarkey, M. D. Lewis, Y. Kishi, T. Kawata, J. R. Bristol, J. R. Rose, D. P. Rossignol, S. Kobayashi, I. Hishinuma, A. Kimura, N. Asakawa, K. Katayama, and I. Yamatsu. 1995. E5531, a pure endotoxin antagonist of high potency. Science 268:80-83.
5. Cohen, J., and J. S. McConnell. 1985. Antibiotic-induced endotoxin release. Lancet ii:1069-1070.
6. Falla, T. J., N. Karunaratne, and R. E. W. Hancock. 1996. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271:19298-19303.
7. Fields, P. I., E. A. Groisman, and F. Heffron. 1989. A Salmonella locus that controls resistance to microbicidal protein from phagocytic cells. Science 243:1059-1062.
8. Friedrich, C., M. G. Scott, N. Karunaratne, H. Van, and R. E. W. Hancock. Salt resistant alpha-helical peptides. Submitted for publication.
9. Gough, M., R. E. W. Hancock, and N. M. Kelly. 1996. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:4922-4927.
10. Greenman, R. L., R. M. Schein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, K. B. Kohler, M. McCarthy, J. Plouffe, J. A. Russell, and The XOMA Sepsis Study Group. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097-1102.
11. Hancock, R. E. W., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
12. Kelly, N. M., L. Young, and A. S. Cross. 1991. Differential induction of tumor necrosis factor by bacteria expressing rough and smooth lipopolysaccharide phenotypes. Infect. Immun. 59:4491-4496.
13. Mathison, J. C., E. Wolfson, and R. J. Ulevitch. 1988. Participation of tumor necrosis factor in the mediation of gram-negative bacteria lipopolysaccharide-induced injury in rabbits. J. Clin. Investig. 88:1925-1937.
14. Moore, R. A., N. C. Bates, and R. E. W. Hancock. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29:496-500.
15. Piers, K. L., M. H. Brown, and R. E. W. Hancock. 1994. Improvement of outer membrane-permeabilizing lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob. Agents Chemother. 38:2311-2316.
16. Piers, K. L., and R. E. W. Hancock. 1994. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Mol. Microbiol. 12:951-958.
17. Rella, M., and D. Haas. 1982. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes. Antimicrob. Agents Chemother. 22:242-249.
18. Richmond. M. H., D. C. Clark, and S. Wotton. 1976. Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains. Antimicrob. Agents Chemother. 10:215-218.
19. Robillard, N. J., and A. L. Scarpa. 1988. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob. Agents Chemother. 32:535-539.
20. Rogy, M. A., L. L. Moldawer, H. S. Oldenburg, W. A. Thompson, W. J. Montegut, S. A. Stackpole, A. Kumar, M. A. Palladino, M. N. Marra, and S. F. Lowry. 1994. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. Ann. Surg. 220:77-85.
21. Schafer, W. M., X. D. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95:1829-1833.
22. Scott, M. G., and R. E. W. Hancock. Unpublished data.
23. Shenep, J. L., R. P. Barton, and K. A. Mogan. 1985. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J. Infect. Dis. 151:1012-11118.
24. Van Deventer, S. J. H., H. R. Buller, J. W. TenCate, A. Sturk, and W. Paul. 1988. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet i:605-608.
25. Wherry, J., R. Wenzel, E. Abraham, R. Allred, R. Balk, R. Bone, H. Levy, S. Nasraway, T. Perl, H. Silverman, R. Wnderink, and The TNF Mab Study Group. 1993. A controlled randomized double blind clinical trial of mono-clonal antibody to tumor necrosis factor (TNF MAb) in patients with sepsis syndrome. Chest 104:3S.
26. Wu, M., and R. E. W. Hancock. 1999. Interaction of the cyclic antimicrobial peptide bactenicin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.